Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents
暂无分享,去创建一个
[1] L. Groop,et al. The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes. , 1984, Acta endocrinologica.
[2] S. Blumenthal. Potentiation of the Hepatic Action of Insulin by Chlorpropamide , 1977, Diabetes.
[3] Rizza Ra. Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: research or clinical practice? , 1985 .
[4] D L Horwitz,et al. Determination of Free and Total Insulin and C-Peptide in Insulin-treated Diabetics , 1977, Diabetes.
[5] D. Schade,et al. Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial. , 1987, JAMA.
[6] B. Burke,et al. Stimulation of residual insulin secretion by glibenclamide in insulin dependent diabetics. , 1980, Acta endocrinologica.
[7] J. Proietto,et al. Differential effects of insulin therapy on hepatic and peripheral insulin sensitivity in Type 2 (non-insulin-dependent) diabetes , 1982, Diabetologia.
[8] N. Nurjhan,et al. Insulin Dose-Response Characteristics for Suppression of Glycerol Release and Conversion to Glucose in Humans , 1986, Diabetes.
[9] L. Heding. Radioimmunological determination of human C-peptide in serum , 1975, Diabetologia.
[10] K. Osei,et al. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Effects on glucoregulation and lipid metabolism. , 1984, The American journal of medicine.
[11] D. Porte,et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.
[12] R. Rizza. Combined Sulfonylurea and Insulin Therapy in Insulin-dependent Diabetes: Research or Clinical Practice? , 1985, Diabetes Care.
[13] J. Tobin,et al. Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. , 1982, The New England journal of medicine.
[14] R. DeFronzo,et al. Splanchnic and Peripheral Disposal of Oral Glucose in Man , 1983, Diabetes.
[15] L. Groop,et al. Different Effects of Glyburide and Glipizide on Insulin Secretion and Hepatic Glucose Production in Normal and NIDDM Subjects , 1987, Diabetes.
[16] K. Minaker,et al. Insulin dose-dependent reductions in plasma amino acids in man. , 1986, The American journal of physiology.
[17] R. Bressler,et al. Clinical Pharmacology of Oral Antidiabetic Agents , 1977 .
[18] B. Volk,et al. PHYSIOLOGICAL BASIS OF THE EFFECTIVENESS OF COMBINED INSULIN‐TOLBUTAMIDE THERAPY IN STABLE DIABETES * , 1959, Annals of the New York Academy of Sciences.
[19] L. Groop,et al. Effect of Glyburide on Glycemic Control, Insulin Requirement, and Glucose Metabolism in Insulin-Treated Diabetic Patients , 1987, Diabetes.
[20] J. A. Scarlett,et al. Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.
[21] L. Groop,et al. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. , 1985, Annals of clinical research.
[22] E. Friedlander. Use of tolbutamide in insulin-resistant diabetes; report of a case. , 1957, The New England journal of medicine.
[23] B. Burke,et al. Improved diabetic control in insulin-dependent diabetics treated with insulin and glibenclamide. , 1984, Acta endocrinologica.
[24] R. DeFronzo,et al. Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.
[25] R. Schifman,et al. Cholesterol in high-density lipoprotein: use of Mg2+/dextran sulfate in its enzymic measurement. , 1978, Clinical chemistry.
[26] R. DeFronzo,et al. Sensitivity of insulin secretion to feedback inhibition by hyperinsulinaemia. , 1981, Acta endocrinologica.
[27] J. Halter,et al. The Effect of Chronic Sulfonylurea Therapy on Hepatic Glucose Production in Non-insulin-dependent Diabetes , 1982, Diabetes.
[28] R. DeFronzo,et al. Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.
[29] R. Tattersall,et al. The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin? , 1984, British medical journal.
[30] O. Owen,et al. Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus. , 1986, Archives of internal medicine.
[31] M. Fabrykant. Favorable effects of supplemental orinase in insulin-treated labile diabetes. , 1957, Metabolism: clinical and experimental.
[32] K. Schöffling,et al. [Glibenclamide-insulin combination in the management of secondary failure of sulfonyl-urea medication]. , 2008, Deutsche medizinische Wochenschrift.
[33] J. Olefsky,et al. Metabolic Consequences of Very-Low-Calorie Diet Therapy in Obese Non-insulin-dependent Diabetic and Nondiabetic Subjects , 1986, Diabetes.
[34] L. Groop,et al. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin dependent diabetics poorly controlled with insulin alone. , 2009, Acta medica Scandinavica.
[35] E. Haupt,et al. [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)]. , 1977, Medizinische Klinik.
[36] B V Howard,et al. Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.
[37] H. Lebovitz,et al. Appraisal of the extrapancreatic actions of sulfonylureas. , 1969, Archives of internal medicine.
[38] K. Polonsky,et al. C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog. , 1984, The Journal of clinical investigation.
[39] M. Riddle. NEW TACTICS FOR TYPE 2 DIABETES: REGIMENS BASED ON INTERMEDIATE-ACTING INSULIN TAKEN AT BEDTIME , 1985, The Lancet.